Scholarlink

Objective <p>To evaluate diagnostic performance of different combinations of acid-fast staining (AFS), Xpert MTB/RIF (Xpert), and <i>Mycobacterium tuberculosis</i> (MTB) culture across sample types in pulmonary tuberculosis (PTB) in a referral center.</p> Methods <p>We conducted a retrospective cross-sectional study on all PTB patients with confirmed microbiological diagnosis in China-Japan Friendship Hospital from January 1st, 2017 to December 31st, 2021. Distribution and sensitivity of different testing strategies were compared for sputum, bronchoalveolar lavage fluid (BALF), and biopsy tissues [transbronchial lung biopsy (TBLB)/transbronchial biopsy (TBB)] using parallel AFS/Xpert/culture combinations.</p> Results <p>1,094 microbiologically diagnosed PTB patients were identified. For sputum samples, the most common testing strategy was parallel AFS/Xpert/culture (42.3%), achieving 89.5% (95%CI 85.7%-92.1%) sensitivity. BALF samples demonstrated similar performance with this combination [86.3% sensitivity, (95%CI 82.1%-89.7%)]. In biopsy tissues, the same triad yielded a sensitivity of 73.8% (95%CI 65.0%-81.5%). Xpert and culture showed partially non-overlapping results in all sample types. A subgroup analysis of sputum tested before bronchoscopy showed 56.5% (95%CI 50.2%-62.7%) sputum Xpert sensitivity and 66.7% (95%CI 58.2%-74.2%) culture sensitivity.</p> Conclusion <p>Simultaneous usage of Xpert, AFS and culture on the same specimen increases MTB testing sensitivity on sputum, BALF and TBB/TBLB, which is valuable for early diagnosis for pulmonary tuberculosis in high-burden settings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Complementary effects of acid-fast staining, culture, and Xpert MTB/RIF® on different respiratory tract samples in a referral center

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月9日

查看全文
  • Siwei Gu,
  • Xiaojing Cui,
  • Chunlei Wang,
  • Lintao Zhong

摘要

Objective

To evaluate diagnostic performance of different combinations of acid-fast staining (AFS), Xpert MTB/RIF (Xpert), and Mycobacterium tuberculosis (MTB) culture across sample types in pulmonary tuberculosis (PTB) in a referral center.

Methods

We conducted a retrospective cross-sectional study on all PTB patients with confirmed microbiological diagnosis in China-Japan Friendship Hospital from January 1st, 2017 to December 31st, 2021. Distribution and sensitivity of different testing strategies were compared for sputum, bronchoalveolar lavage fluid (BALF), and biopsy tissues [transbronchial lung biopsy (TBLB)/transbronchial biopsy (TBB)] using parallel AFS/Xpert/culture combinations.

Results

1,094 microbiologically diagnosed PTB patients were identified. For sputum samples, the most common testing strategy was parallel AFS/Xpert/culture (42.3%), achieving 89.5% (95%CI 85.7%-92.1%) sensitivity. BALF samples demonstrated similar performance with this combination [86.3% sensitivity, (95%CI 82.1%-89.7%)]. In biopsy tissues, the same triad yielded a sensitivity of 73.8% (95%CI 65.0%-81.5%). Xpert and culture showed partially non-overlapping results in all sample types. A subgroup analysis of sputum tested before bronchoscopy showed 56.5% (95%CI 50.2%-62.7%) sputum Xpert sensitivity and 66.7% (95%CI 58.2%-74.2%) culture sensitivity.

Conclusion

Simultaneous usage of Xpert, AFS and culture on the same specimen increases MTB testing sensitivity on sputum, BALF and TBB/TBLB, which is valuable for early diagnosis for pulmonary tuberculosis in high-burden settings.